Natalia Valdiviezo

发表

Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC.

P. Jänne, D. Planchard, Y. Rukazenkov, 2023, The New England journal of medicine.

CNS Efficacy of Osimertinib With or Without Chemotherapy in Epidermal Growth Factor Receptor–Mutated Advanced Non–Small-Cell Lung Cancer

P. Jänne, B. Chewaskulyong, D. Planchard, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Subcutaneous Trastuzumab: An Observational Study of Safety and Tolerability in Patients With Early HER2-Positive Breast Cancer

T. Vidaurre, S. Neciosup, Z. Morante, 2024, International journal of breast cancer.